# Junrou Technology

> Chinese brain-computer interface developer working on miniature neural electrodes and sensing systems.

## Why it is interesting

Junrou disclosed an Angel+ financing equivalent to nearly $15 million in USD on November 2, 2026, led by Shunwei Capital, to advance movable NeuroWorm electrodes and preclinical research.

## Profile

- **Latest funding:** Angel+ (USD-equivalent estimate) — Nearly $15 million (approximate USD equivalent) (November 2, 2026)
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** $15M
- **Stage:** pre-seed
- **Status:** private
- **Industries:** N/A
- **Coverage:** full
- **Last updated:** 2026-11-02
- **Latest funding investors:** Shunwei Capital, Hillhouse Ventures, AgiBot, Nansha Qisheng

## Key facts

- Angel+ financing worth nearly $15M USD equivalent announced November 2, 2026.
- Shunwei Capital led, with Hillhouse Ventures, AgiBot and Nansha Qisheng participating.
- Funding supports prototype manufacturing, GMP-oriented lines, animal studies and signal processing.

## Funding history

- Angel+ (USD-equivalent estimate) · Nearly $15 million (approximate USD equivalent) · November 2, 2026
  Source: https://www.36kr.com/p/4051950800623238

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** November 2, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/junrou-technology